We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
Thanks to our healthcare, teaching and research potential, we work to incorporate new knowledge to generate value for patients, professionals and the organization itself.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
The complexity of the diagnoses and treatments performed by the Medical Oncology Department requires working in multidisciplinary teams of specialists, with the aim of providing an integrated approach from diagnosis to the end of treatment. For this same reason, we work in expert cancer-specific committees and assess each case as a team to determine the appropriate treatment for each person. If you train with us, you will be working with highly qualified professionals and the latest generation technology. Training is backed up by our own training programmes and through collaboration with centres of recognised quality and prestige.
Medical Oncology training itinerary
The core of this teaching unit is provided by the Medical Oncology Department, with participation from Haematology, Internal Medicine, Radiation Oncology, Radiology, Pathological Anatomy, Infectious Diseases and Palliative Care, the Intensive Care Unit and the A&E Department. The Unit can accommodate three residents per year. Residents’ training in Medical Oncology takes five years in total. The two first years are spent on core training, with the following three years dedicated specifically to specialisation.
Residents in medical oncology are expected to have in-depth knowledge of preventative, diagnostic and therapeutic choices for cancer. For this reason it is important that they continuously update their knowledge of cancer biology. To this end, they must take part in research projects that promote excellence in research. They will also have the opportunity to become familiar with the main lines of research in the Department and to take part in some of them. Over the course of training, residents learn to have a critical and open approach to the high volume of clinical studies and advances in the specialisation, whilst always keeping ethical considerations at the forefront of their work.
Why do your residency at Vall d’Hebron?
Elena Élez is an attending phisicyan of the Gastrointestinal Tumors Service of the Medical Oncology Service of the Vall d'Hebron University Hospital. She is currently also Principal Investigator of the Gastrointestinal Tumor Group and Endocrine of VHIO, headed by Josep Tabernero, director of VHIO.
Paediatric Oncology and Haematology, Children's Hospital and Woman's Hospital
Researcher, Vall d’Hebron Institute of Oncology
Medical Oncology, General Hospital
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Vall d’Hebron University Hospital Foundation – Research Institute. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.